Total amount: € 0,00
HOW TO ORDER
A Journal on Psychiatry, Psychology and Psychopharmacology
Official Journal of the Italian Society of Social Psychiatry
Indexed/Abstracted in: EMBASE, e-psyche, PsycINFO, Scopus, Emerging Sources Citation Index
Minerva Psichiatrica 2015 March;56(1):1-12
How much is decision-making in the antipsychotic treatment shared among psychiatrists-patients-relatives? The “Farmaci e Famiglie” project in mental health department of the Bologna Health Authority
Gallingani F. 1, Piccinni C. 2, Poluzzi E. 2, Romagnoli G. 3, De Ponti F. 2, Berardi D. 1, 4, Fioritti A. 4, Ferrari Gozzi B. 1, Montardi G. 1, Micheloni B. 1, Tarricone I. 1, 4, Donegani I. 4
1 Unità di Psichiatria, Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna, Bologna, Italia;
2 Unità di Farmacologia, Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna, Bologna, Italia;
3 Gruppi di Auto Mutuo Aiuto di Bologna Bologna, Italia;
4 Dipartimento di Salute Mentale e Dipendenze Patologiche, AUSL di Bologna, Bologna, Italia
AIM: Aim of the present study was to describe the protocol of “Farmaci e Famiglie” project aimed to evaluate: 1) the degree of shared-decision making of pharmacological treatments among clinicians, patients and relatives/carers; 2) their concordance in the perception of benefits and side effects of antipsychotics.
METHODS: Fifty patients will be randomly selected in each of the 11 Community Mental Health Centers (CMHCs) of Bologna, using two inclusion criteria: to have been followed by the CMHCs for at least 6 months, and to be receiving antipsychotics. Questionnaires will be administered to patients, carers and clinicians in order to evaluate the sharing of choice of treatment and the concordance in the perception of benefits and side effects of antipsychotic treatments. They will be filled-in anonymously by all the subjects involved after having signed consensus form. The concordance in the opinions will be investigated. The Project has been approved by the local Ethical Committee.
RESULTS: Results should show the degree of concordance of the opinions on shared-decision making process, perceived antipsychotic benefits and side effects. This project will provide the following benefits: patients and carers could obtain more pieces of information on drugs and activities promoted by CMHCs; clinicians will be aware of the opinions and the perceptions of patients and carers about therapies; CMHCs could ameliorate their supplied services.
CONCLUSION: This project is going to give an important contribution to the implementation of the shared-decision making process in the CMHCs. The findings will allow the services to promote a patient-centered treatment and a better communication among patient-carer clinician.